646 studies found for:    DMD
Show Display Options
Rank Status Study
21 Active, not recruiting Extension Study of Drisapersen in DMD Subjects
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Drisapersen
22 Not yet recruiting Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD
Condition: Muscular Dystrophy, Duchenne
Interventions: Other: Cardiac MRI with contrast;   Other: Cardiac MRI without contrast;   Other: Blood Test;   Other: Heart Rate;   Other: Pulmonary Function Test;   Other: Genetic Testing;   Other: Repeat MRI scan
23 Active, not recruiting Phase I/II Study of SRP-4053 in DMD Patients
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Placebo;   Drug: SRP-4053
24 Active, not recruiting Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy
Conditions: Muscular Dystrophy, Duchenne;   Muscular Dystrophies;   Muscular Disorders, Atrophic;   Muscular Diseases;   Musculoskeletal Diseases;   Neuromuscular Diseases;   Nervous System Diseases;   Genetic Diseases, X-Linked;   Genetic Diseases, Inborn
Interventions: Drug: Ataluren;   Drug: Placebo
25 Enrolling by invitation Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: rAAVrh74.MCK.micro-Dystrophin
26 Completed A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
Condition: Muscular Dystrophies
Intervention: Drug: GSK2402968 6mg/kg/week
27 Terminated Study of Ataluren (PTC124®) in Nonambulatory Patients With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy
Intervention: Drug: Ataluren (PTC124)
28 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
29 Completed Cardiomyopathy in DMD: Lisinopril vs. Losartan
Conditions: Duchenne Muscular Dystrophy (DMD);   Cardiomyopathy
Interventions: Drug: Losartan;   Drug: Lisinopril
30 Active, not recruiting Upper Limb Assessment in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention:
31 Completed Research of Biomarkers in Duchenne Muscular Dystrophy Patients
Condition: Duchenne Muscular Dystrophy (DMD)
Intervention:
32 Suspended Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: HT-100
33 Not yet recruiting A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Condition: Duchenne Muscular Dystrophy (DMD)
Interventions: Drug: Idebenone 150 mg film-coated tablets;   Drug: placebo
34 Active, not recruiting A Phase I/II Study of PRO053 in Subjects With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Cohort 1;   Drug: Cohort 2;   Drug: 48-week treatment phase
35 Recruiting Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Distrophy (DMD)
Intervention: Other: Muscle biopsy
36 Active, not recruiting Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy (DMD)
Intervention: Drug: AVI-4658 (Eteplirsen)
37 Enrolling by invitation Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: rAAV1.CMV.huFollistin344
38 Completed Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: PTC124
39 Enrolling by invitation Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne's Muscular Dystrophy
Intervention: Biological: Umbilical Cord Mesenchymal Stem Cells
40 Recruiting L-citrulline and Metformin in Duchenne's Muscular Dystrophy
Condition: Duchenne's Muscular Dystrophy (DMD)
Interventions: Drug: 750 mg metformin and 7.5 g L-citrulline daily p.o.;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years